Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemiaDavide Rossi, Marco Ladetto, Paola Omedè et al.|Leukemia|2009Cited by 98
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphomaSimone Ferrero, Marco Ladetto, Angela Gueli et al.|Annals of Hematology|2013Cited by 20
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: Evidence for premature aging of the myeloid compartmentChiara Lobetti‐Bodoni, Marco Ladetto, Giovanni Grignani et al.|Mechanisms of Ageing and Development|2012Cited by 9
Telomere Length Is An Independent Predictor of Survival, Treatment Requirement and Richter’s Syndrome Transformation in Chronic Lymphocytic Leukemia.Davide Rossi, Marco Ladetto, Paola Omedè et al.|Blood|2008Cited by 1
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow‐upPaola Ghione, Simone Ferrero, Paola Omedè et al.|British Journal of Haematology|2017Cited by 1